Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

10.73
-0.6620-5.81%
Post-market: 10.70-0.0340-0.32%19:52 EDT
Volume:474.15K
Turnover:5.19M
Market Cap:65.59M
PE:-0.21
High:12.52
Open:12.48
Low:10.47
Close:11.39
52wk High:309.60
52wk Low:9.10
Shares:6.11M
Float Shares:3.83M
Volume Ratio:3.29
T/O Rate:12.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-51.9692
EPS(LYR):-59.6431
ROE:-783.37%
ROA:-62.39%
PB:-0.70
PE(LYR):-0.18

Loading ...

Gossamer Bio price target lowered to $2 from $5 at H.C. Wainwright

TIPRANKS
·
Jun 26

Gossamer Bio Insiders Are Down US$45k But Regain Some Losses

Simply Wall St.
·
Jun 18

Gossamer Bio announces final tender results

TIPRANKS
·
Jun 17

Gossamer Bio says $18.95 million of 5% convertible notes due 2027 remain after exchange offer

Reuters
·
Jun 17

Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation With Respect to Existing Convertible Notes

THOMSON REUTERS
·
Jun 17

Gossamer Bio - $181.1 Mln of Existing Convertible Notes Tendered as of June 2, 2026

THOMSON REUTERS
·
Jun 17

Gossamer Bio - Eliminates Most Restrictive Covenants and Events of Default on Existing Notes

THOMSON REUTERS
·
Jun 17

Harbour BioMed appoints Luisa Salter-Cid as scientific advisor

Reuters
·
Jun 11

Gossamer Bio accepts early tenders of USD 181.05 million 5% convertible notes in exchange offer

Reuters
·
Jun 05

Gossamer Bio shareholders re-elect Hasnain, Cox to board as Class II directors

Reuters
·
Jun 05

Gossamer Bio announces early tender results, early settlement of solicitation

TIPRANKS
·
Jun 03

Gossamer Bio Reports Early Tender Results for Exchange Offer

MT Newswires Live
·
Jun 03

Gossamer Bio accepts $181.05 million early tenders in convertible notes exchange offer

Reuters
·
Jun 03

Gossamer Bio extends early tender date for exchange offer on 5% convertible notes due 2027

Reuters
·
Jun 02

Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation With Respect to Existing Convertible Notes

THOMSON REUTERS
·
Jun 02

Analysts Are Bullish on Top Healthcare Stocks: Monopar Therapeutics Inc (MNPR), Gossamer Bio (GOSS)

TIPRANKS
·
Jun 01

Investors Sue Gossamer Bio (GOSS) Over Inflated Blood Pressure Study Claims

TIPRANKS
·
May 29

Gossamer Bio Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
May 26

Gossamer Bio Is Maintained at Underweight by Barclays

Dow Jones
·
May 19

Guggenheim Reaffirms Their Hold Rating on Gossamer Bio (GOSS)

TIPRANKS
·
May 19